Servier Acquires Shire Oncology Business For $2.4bn

 
• By Mike Ward

French pharma Servier takes step to meet its strategic ambition of becoming a global player in oncology by acquiring Shire's cancer franchise for $2.4bn

Spoons
Will selling some of the family silver deter Takeda? • Source: Shutterstock

More from Deals

More from Business